Accessing cerebrospinal fluid (CSF) from the craniocervical junction through the posterior atlanto-occipital membrane via cerebellomedullary injection (also known as cisternal puncture or cisterna magna injection) has become a standard procedure in preclinical studies. Such delivery provides broader coverage to the central and peripheral nervous system unlike local parenchymal delivery alone. As a clinical application, this approach offers a more reliable method for neurological gene replacement delivery in infants, where skull-mounted devices are not indicated. Here we describe a consistent, precise, and safe method for CSF injection with minimal equipment and technical skills
In the context of motoneuron diseases, gene delivery as an experimental or therapeutic approach is h...
Gene therapy is an attractive option for treatment of neurological diseases. Delivery of the therape...
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease resulting from deficiency of the...
Global gene delivery to the CNS has therapeutic importance for the treatment of neurological disorde...
Adeno-associated virus serotype 9 (AAV9) vectors have recently been shown to transduce cells through...
The collection of cerebrospinal fluid is necessary in order to determine its composition. It can the...
Injection of AAV into the cerebrospinal fluid (CSF) offers a means to achieve widespread transgene d...
Cisterna magna cannulation (CMc) is a straightforward procedure that enables direct access to the ce...
Drug delivery to the central nervous system (CNS) is complicated by the blood-brain barrier. As a re...
Adeno-associated virus (AAV) gene therapy constitutes a powerful tool for the treatment of neurodege...
Recombinant AAV-mediated gene delivery to the CNS can be performed either by direct delivery at the ...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
The present study was designed to characterize transduction of non-human primate brain and spinal co...
Correction of perinatally lethal neurogenetic diseases requires efficient transduction of several ce...
In the context of motoneuron diseases, gene delivery as an experimental or therapeutic approach is h...
Gene therapy is an attractive option for treatment of neurological diseases. Delivery of the therape...
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease resulting from deficiency of the...
Global gene delivery to the CNS has therapeutic importance for the treatment of neurological disorde...
Adeno-associated virus serotype 9 (AAV9) vectors have recently been shown to transduce cells through...
The collection of cerebrospinal fluid is necessary in order to determine its composition. It can the...
Injection of AAV into the cerebrospinal fluid (CSF) offers a means to achieve widespread transgene d...
Cisterna magna cannulation (CMc) is a straightforward procedure that enables direct access to the ce...
Drug delivery to the central nervous system (CNS) is complicated by the blood-brain barrier. As a re...
Adeno-associated virus (AAV) gene therapy constitutes a powerful tool for the treatment of neurodege...
Recombinant AAV-mediated gene delivery to the CNS can be performed either by direct delivery at the ...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
The present study was designed to characterize transduction of non-human primate brain and spinal co...
Correction of perinatally lethal neurogenetic diseases requires efficient transduction of several ce...
In the context of motoneuron diseases, gene delivery as an experimental or therapeutic approach is h...
Gene therapy is an attractive option for treatment of neurological diseases. Delivery of the therape...
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease resulting from deficiency of the...